MedMark Treatment Centers in Baltimore: Opioid Addiction Treatment in Cherry Hill
MedMark Treatment Centers operates a medication-assisted treatment (MAT) clinic in Baltimore's Cherry Hill neighborhood, offering primarily methadone maintenance and buprenorphine services for individuals with opioid use disorder. The center anchors care in Baltimore's South Baltimore medical corridor and serves a largely uninsured and underinsured patient population, accepting Medicaid and a sliding fee scale.
What MedMark actually is
MedMark is a freestanding opioid treatment program (OTP) licensed by the federal Substance Abuse and Mental Health Services Administration (SAMHSA) and the State of Maryland. It is not a psychiatric hospital or hospital-based clinic; it is a medication and counseling hub focused on stabilizing people with opioid dependence through regulated pharmacotherapy. The Cherry Hill location is one of multiple MedMark sites in Maryland and Pennsylvania, though it is the primary Baltimore facility. Patients attend regularly, either daily (for methadone) or less frequently (for buprenorphine), depending on their treatment phase and medication.
Methadone vs. buprenorphine at MedMark
MedMark offers both methadone and buprenorphine. Methadone requires daily observed dosing for most patients in the early phase of treatment, then gradually shifts to takeaway doses as compliance and stabilization improve. Buprenorphine (a partial opioid agonist) typically permits less frequent clinic visits and is increasingly preferred by patients seeking flexibility. The choice between the two depends on opioid dependence severity, prior treatment response, and personal preference. Someone with severe heroin dependence and multiple relapse attempts may stabilize faster on methadone; someone seeking to minimize clinic time and avoid daily observed dosing may prefer buprenorphine, though it is more likely to precipitate withdrawal if not dosed carefully during transition.
Services and pricing
MedMark provides medication dispensing, urinalysis, group and individual counseling, case management, and psychiatric evaluation. The initial medical evaluation costs vary but are often covered by Medicaid; uninsured patients are typically assessed on a sliding scale, with reported initial assessments ranging from $100 to $300 depending on income. Monthly medication and counseling fees also run on a sliding scale; contact the clinic directly to confirm current rates, as Medicaid reimbursement changes annually. The program does not charge per counseling session to patients already enrolled in medication maintenance; counseling is bundled into the monthly fee. This contrasts sharply with private outpatient mental health clinics, where a single session may cost $150 to $250 out of pocket.
How it compares to other Baltimore opioid treatment options
Baltimore has approximately four SAMHSA-licensed opioid treatment programs. The largest competitor is Bay Clinic at Johns Hopkins, which offers both methadone and buprenorphine in a hospital-affiliated setting; Bay Clinic's integration into Hopkins' system allows quicker psychiatric referral and medical coordination but typically requires active Hopkins health-system affiliation for new patients. Behavioral Health System Baltimore (part of the University of Maryland system) operates REACH! as an additional hub. Harbor Hospital Center also offers OTP services. MedMark's Cherry Hill location draws patients who either live in South Baltimore or who seek a non-hospital-affiliated, more decentralized clinic environment. Its sliding scale is notably accessible to uninsured patients compared to hospital-based programs, which may require Medicaid or private insurance upfront.
Who it suits and who it does not suit
MedMark suits people with confirmed opioid dependence (not recreational use or experimentation), those insured by Medicaid or without insurance, and those willing to commit to regular clinic attendance. It is well-matched for individuals seeking methadone (who must attend daily in early phases) and for those needing structured wraparound services like counseling within a single facility. It does not suit patients seeking office-based buprenorphine at a primary-care doctor's office (available from many Baltimore internists and family medicine providers under the DATA 2000 waiver). It is not appropriate for individuals in early alcohol use disorder who need concurrent addiction psychiatry, though MedMark provides referrals and limited psychiatric screening.
First visit and intake process
New patients typically attend an intake appointment lasting 1.5 to 2 hours, during which medical history, substance use history, and psychiatric screening occur. Urine testing confirms opioid metabolites. If accepted, methadone patients begin dosing the same day (under observation) at a low dose, typically 30 to 40 mg, which is increased over subsequent days under medical supervision. Buprenorphine induction is gentler, beginning at a lower dose and scaling upward over days without requiring daily visits immediately. Initial appointments are by referral or walk-in application; verify current intake procedures by calling ahead.
Hours, parking, and logistics
MedMark's Cherry Hill location operates Monday through Friday, generally 6:00 am to 2:00 pm, with limited Saturday hours; verify current hours, as they sometimes adjust seasonally or with staffing changes. Street parking is available; the clinic does not maintain a dedicated lot. Public transit (MTA bus lines serving South Baltimore) provides access. Cherry Hill is a neighborhood in transition; the clinic is situated near medical and social-service infrastructure but in a lower-income area.
MedMark's strength lies in its accessibility to uninsured and Medicaid populations and its unwavering focus on opioid maintenance in a community where overdose remains a leading cause of death among working-age adults.
